Performance-Enhancing Drugs

PM and R

Volumn 2, Issue 4, 2010, Pages 285-293

  Finnoff, Jonathan T ^a   Chimes, Gary P ^b   Murray, Thomas H ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c HASTINGS CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANABOLIC AGENT; ANDROGEN; CLENBUTEROL; COCAINE; CORTICOSTEROID; DIAMORPHINE; ERYTHROPOIETIN; INSULIN; TESTOSTERONE;

ALERTNESS; ATHLETE; ATHLETIC PERFORMANCE; BLOOD CLOTTING DISORDER; BODY HEIGHT; CARDIOMYOPATHY; CRIMINAL LAW; DOPING; DRUG FATALITY; DYSLIPIDEMIA; EDITORIAL; ENDURANCE; GOVERNMENT REGULATION; HEALTH HAZARD; HEART ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; HYPOGLYCEMIA; HYPOGONADISM; INFERTILITY; INTRAHEPATIC CHOLESTASIS; LIVER CELL CARCINOMA; MAJOR DEPRESSION; MEDICAL ETHICS; MORALITY; NERVE CELL NECROSIS; PELIOSIS HEPATIS; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PRIVACY; PROSTATE HYPERTROPHY; SPORTING EVENT; SPORTS MEDICINE; TENDINITIS; TENDON RUPTURE; THROMBOCYTE DISORDER;

ADULT; ANABOLIC AGENTS; BICYCLING; DOPING IN SPORTS; HUMANS; MALE; PHYSICIAN'S ROLE;

EID: 77951940289     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2010.03.016     Document Type: Editorial

References (21)

1. World Anti-Doping Agency. Homepage. www.wada-ama.org Accessed March 15, 2010
2. Sjoqvist F., Garle M., and Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet 371 (2008) 1872-1882
3. United Nations Educational, Scientific and Cultural Organization. International Convention against Doping in Sport. http://portal.unesco.org/shs/en/ev.php-URL_ID=9682&URL_DO=DO_TOPI C&URL_SECTION=201.html Accessed March 15, 2010
4. Larriviere D., Williams M.A., Rizzo M., and Bonnie R.J. Responding to requests from adult patients for neuroenhancements. Guidance of the ethics, law and humanities committee. Neurology 73 (2009) 1-7
5. Kanayama G., Hudson J.I., and Pope H.G. Long-term psychiatric and medical consequences of AAS abuse: A looming public health concern?. Drug Alcohol Depend 98 (2008) 1-12
6. Hoffman J.R., and Ratamess N.A. Medical issues associated with anabolic steroid use: Are they exaggerated. J Sports Sci Med 5 (2006) 182-193
7. Bhasin S., Woodhouse L., Casaburi R., et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 281 (2001) E1172-E1181
8. Bhasin S., Storer T.W., Berman N., et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 335 (1996) 1-7
9. Nindl B.C., Barnes B.R., and Alemany J.A. Physiologic consequences of U.S. Army Ranger training. Med Sci Sports Exerc 39 (2007) 1380-1387
10. Bouton J. Ball Four (1990), Collier Books, New York
11. Kayser B., and Smith A.C. Globilisation of anti-doping: The reverse side of the medal. BMJ 337 (2008) a584
12. Miller G. Neuropathology, a late hit for pro football players. Science 325 (2009) 670-672
13. McKee A.C., Cantu R.C., Nowinski C.J., et al. Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 68 (2009) 709-735
14. Hoffman J., and Ratamess N.A. Medical issues associated with anabolic steroid use: Are they exaggerated?. J Sports Sci Med 5 (2006) 182-193
15. Kanayama G., Hudson J.I., and Pope H.G. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: A looming public health concern?. Drug Alcohol Depend 98 (2008) 1-12
16. Parssinen M., Kujala U., Vartiainen E., Sarna S., and Seppala T. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 21 (2000) 225-227
17. Mirkin G. Review of Death in the Locker Room: Steroids and Sports. JAMA 252 (1984) 2771
18. Hoffman J., and Ratamess N.A. Medical issues associated with anabolic steroid use: Are they exaggerated?. J Sports Sci Med 5 (2006) 182-193
19. Hartgens F., Cheriex E.C., and Kuipers H. Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes. Int J Sports Med 24 (2003) 344-351
20. Alexander B. Good cop, bad cop. Outside Magazine. http://outside.away.com/outside/culture/201001/zach-lund-wada-1.html Accessed March 15, 2010
21. Sjöqvist F., Garle M., and Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet 371 (2008) 1872-1882